- Home
- ABEO vs JGH Comparison
ABEO vs JGH Comparison
Compare ABEO & JGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABEO | JGH |
|---|---|---|
| Founded | 1974 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.5M | 355.8M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABEO | JGH |
|---|---|---|
| Price | $5.34 | $12.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 69.7K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.85% |
| EPS Growth | ★ 165.16 | N/A |
| EPS | ★ 1.01 | N/A |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | $1,024.31 | N/A |
| Revenue Next Year | $145.42 | N/A |
| P/E Ratio | $5.34 | ★ N/A |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $4.00 | $11.80 |
| 52 Week High | $7.54 | $13.70 |
Technical Indicators
Market Signals| Indicator | ABEO | JGH |
|---|---|---|
| Relative Strength Index (RSI) | 56.63 | 53.78 |
| Support Level | $5.24 | $12.38 |
| Resistance Level | $5.62 | $12.94 |
| Average True Range (ATR) | 0.24 | 0.17 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 55.38 | 37.84 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income. The Fund's securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.